Your browser doesn't support javascript.
loading
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
Ke, Liangru; Zhou, Hufeng; Wang, Chong; Xiong, Geng; Xiang, Yanqun; Ling, Yihong; Khabir, Abdelmajid; Tsao, George S; Zeng, Yixin; Zeng, Musheng; Busson, Pierre; Kieff, Elliott; Guo, Xiang; Zhao, Bo.
Afiliação
  • Ke L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Zhou H; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Wang C; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Xiong G; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Xiang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Ling Y; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Khabir A; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Tsao GS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Zeng Y; Pathology Department, Habib Bourguiba Hospital, 4100 Medenine, Tunisia.
  • Zeng M; School of Medicine, University of Sfax, 3029 Sfax, Tunisia.
  • Busson P; Department of Anatomy, Center for Cancer Research, University of Hong Kong, Hong Kong, People's Republic of China.
  • Kieff E; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Guo X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China; bzhao@bwh.harvard.edu guoxiang@sysucc.org.cn ekieff@bwh.harvard.edu pierre.busson@gustaveroussy.fr zengmsh@mail.sy
  • Zhao B; CNRS, UMR 8126, Gustave Roussy, Université Paris-Saclay, F-94805 Villejuif, France bzhao@bwh.harvard.edu guoxiang@sysucc.org.cn ekieff@bwh.harvard.edu pierre.busson@gustaveroussy.fr zengmsh@mail.sysu.edu.cn.
Proc Natl Acad Sci U S A ; 114(36): 9683-9688, 2017 09 05.
Article em En | MEDLINE | ID: mdl-28831010
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma / Neoplasias Nasofaríngeas / Elementos Facilitadores Genéticos / Proteínas Proto-Oncogênicas c-ets Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma / Neoplasias Nasofaríngeas / Elementos Facilitadores Genéticos / Proteínas Proto-Oncogênicas c-ets Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article